Obesity increases risk of developing cancer

May 12, 2015
Obesity increases risk of developing cancer
Obesity increases risk of developing cancer

Cancer is more likely to develop in people who are very overweight (obese), because surplus body fat interferes with various hormone cycles and with glucose and fat metabolism. On the occasion of European Obesity Day this coming Saturday (16 May), metabolic expert Alexandra Kautzky-Willer, Comprehensive Cancer Center (CCC) at MedUni Vienna and Vienna General Hospital, draws attention to the fact that, even in Austria, more and more people are suffering from obesity. Several studies are therefore being conducted at CCC to investigate the links between obesity, metabolic disorders and cancer.

Obesity is very much on the increase in . Currently 15% of men and 10% of women in Austria are morbidly obese. The latest studies show that young women and postmenopausal women are particularly affected by this negative trend. Adults are regarded as being obese if they have a Body Mass Index (BMI) of more than 30. A BMI of between 18.5 and 24.9 is considered normal but, at a BMI of more than 25, you are considered to be overweight.

Abdominal fat is particularly dangerous

New data from an international study, which was published in Lancet Oncology in 2015, show that 5.4% of all cancers in women and 1.9% of cancers in men are associated with a high BMI. This is particularly true of cancers of the oesophagus, bowel, kidneys, pancreas and – in women – the gallbladder, ovaries, uterus and postmenopausal breast . Endocrinologist and consultant in gender medicine, Alexandra Kautzky-Willer, Vice Principal of the University Department of Internal Medicine III of MedUni Vienna and member of the Comprehensive Cancer Center (CCC) Vienna: "People with a BMI of 30 and above are predominantly affected. An increase in BMI by only a factor of 1, for example from 29 to 30, increases your by between 3% and 10% for the said types of cancer. Particularly abdominal fat, also known as visceral fat, has a negative impact on health, since it increases your cancer risk and encourages the development of such as diabetes, or cardiovascular disease."

Fatty deposits in the abdominal area increase the cancer risk for several reasons: first of all, fatty tissue is hormonally active, produces adipose tissue hormones and changes the balance of sex hormones – for example by converting more androgen precursors into oestrogen. This encourages the development and growth of hormone-related tumours, such as various forms of breast cancer or endometrial cancer. The detrimental shift in the balance of sex hormones and adipose tissue hormones directly and indirectly encourages tumour growth. It also leads to an increase in insulin resistance, which the body responds to in turn by increasing insulin production. Kautzky-Willer: "The problem with that is that insulin not only regulates the metabolism but can also act as a growth-stimulating hormone and encourage cell division and hence tumour growth. We can therefore see a close relationship between diabetes and certain types of cancer, in particular liver and pancreatic cancer. High blood sugar levels also seem to further promote tumour growth." Another aspect is that chronic inflammatory processes can occur in the region of the abdominal fat and these also favour the development of cancer. Kautzky-Willer: "The positive thing is that you can do something about this risk by losing weight or keeping an eye on your weight from the outset. Many types of cancer could be easily avoided in this way; a Mediterranean diet and exercise also help."

Further research into the links

At the Comprehensive Cancer Center (CCC) of MedUni Vienna and Vienna General Hospital they are conducting further research into the links between obesity, diabetes and cancer. For example, the CANDY study (CANCER AND DIABESITY) has been set up. This looks at the link between diabetes and tumour diseases. Other studies are investigating the influence of various diabetes drugs on the development of cancer and the course of the disease. This should help to further improve drug treatments.

Abdominal girth a better marker than BMI

Although, even in scientific publications, the BMI is commonly used as a guide value, experts only regard it as a general marker. Kautzky-Willer: "The BMI relates to body weight and makes no distinction between fatty tissue and muscle mass. So, for example, a bodybuilder, who is very heavy because of his muscle mass but hardly has any fat at all, would have a very high BMI. Abdominal girth, on the other hand, is a much more reliable indicator of overweight or , because it can be used to specifically determine the proportion of ."

Explore further: Unhealthy insulin levels may boost breast cancer risk

More information: "Global burden of cancer attributable to high body-mass index in 2012: a population-based study." DOI: dx.doi.org/10.1016/S1470-2045(14)71123-4

Related Stories

Unhealthy insulin levels may boost breast cancer risk

January 15, 2015
(HealthDay)—After menopause, unhealthy insulin levels may predict breast cancer risk even more than excess weight, new research suggests.

Blood test replaces surgery for bowel tumor assessment

March 18, 2015
A new study at the MedUni Vienna's Comprehensive Cancer Center (CCC) is assessing patients with metastasised bowel cancer to determine whether it is possible to characterise tumour and better control resistance mechanisms ...

Radiographic imaging exposes relationship between obesity and cancer

December 4, 2013
Researchers at the National Institute for Aging are working to improve understanding about obesity and cancer. A study, published today in the journal Applied Physiology, Nutrition, and Metabolism, is the first to use direct ...

Women are more prone to hypoglycaemia than men

June 27, 2012
Just how important a gender-specific perspective and the personalised treatment of illnesses are between men and women is being demonstrated by two current studies at the MedUni Vienna, which are being led by Alexandra Kautzky-Willer ...

Body Mass Index associated with breast cancer, regardless of body shape

April 16, 2014
A study of predominantly white women finds a larger waist circumference is associated with higher risk of postmenopausal breast cancer, but not beyond its contribution to BMI. The study, by American Cancer Society researchers, ...

Location of body fat can elevate heart disease, cancer risk

July 10, 2013
Individuals with excessive abdominal fat have a greater risk of heart disease and cancer than individuals with a similar body mass index (BMI) who carry their fat in other areas of the body, according to a study published ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.